|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.62 CNY | -1.40% |
|
+6.44% | -24.87% |
Shanghai Shen Lian Biomedical Corporation reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 328.59 million compared to CNY 358.43 million a year ago. Net income was CNY 61.59 million compared to CNY 110.2 million a year ago.
Basic earnings per share from continuing operations was CNY 0.15 compared to CNY 0.27 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.87% | 319M | |
| -14.35% | 77.13B | |
| +14.09% | 8.4B | |
| +27.62% | 3.79B | |
| -0.70% | 3.22B | |
| +14.70% | 1.64B | |
| -10.12% | 1.5B | |
| -22.60% | 1.3B | |
| -3.81% | 1.25B | |
| -10.26% | 1.18B |
SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION 
